References
1.
National Institutes of Health. Accessed September 26, 2022. https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq.
2.
American Society of Clinical Oncology Publications. Accessed September 26, 2022. https://www.cancer.net/cancer-types/lung-cancer-non-small-cell/statistics.
3.
National Cancer Institute. Accessed January 12, 2023. https://www.cancer.gov/types/leukemia/patient/adult-aml-treatment-pdq.
4.
Cancert.Net. Accessed January 12, 2023. https://www.cancer.net/cancer-types/leukemia-acute-myeloid-aml/statistics.
5.
National Cancer Institute. Accessed January 12, 2023. https://www.cancer.gov/types/myeloproliferative/patient/myelodysplastic-treatment-pdq#:~:text=Myelodysplastic%20syndromes%20are%20a%20group,blood%20cells%20and%20bone%20marrow.
6.
Tricot GJ, Lauer RC, Appelbaum FR, et al.: Management of the myelodysplastic syndromes. Semin Oncol 14 (4): 444-53, 1987.[PUBMED Abstract]